Fidelity® MSCI Health Care ETF (FHLC)
45.50
+0.02 +0.04%
NYSE Arca
Oct 17, 12:20
Delayed 2m
USD
FHLC Key Stats
| Net Asset Value | Upgrade |
| Discount or Premium to NAV | Upgrade |
| Turnover Ratio | Upgrade |
| 1 Year Fund Level Flows | Upgrade |
View All FHLC News
FHLC News
-
WireHeadlineTime (ET)
-
SA Breaking News08/24 04:46
-
SA Breaking News08/15 10:32
-
SA Breaking News08/01 08:24
-
SA Breaking News07/13 07:53
-
SA Breaking News10/30 14:55
-
SA Breaking News10/25 19:18
-
SA Breaking News10/17 14:47
-
SA Breaking News10/13 02:38
-
SA Breaking News09/29 17:23
-
SA Breaking News09/22 14:21
FHLC Performance
| Total Return (Price) | Total Return (NAV) | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|---|
| 1M | -1.09% | -1.07% | -5.89% | 31 |
| 3M | 6.19% | 6.17% | -2.23% | 11 |
| 6M | 13.59% | 13.49% | 8.07% | 27 |
| YTD | 14.84% | 14.81% | 10.29% | 38 |
| 1Y | 16.28% | 16.21% | 10.83% | 38 |
| 3Y | 12.47% | 12.43% | 8.91% | 26 |
| 5Y | -- | -- | 13.00% | -- |
| 10Y | -- | -- | 16.45% | -- |
FHLC Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.07% | 0.07% | 0.00% |
| Stock | 99.93% | 99.93% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.00% | 0.00% | 0.00% |
FHLC Region Exposure
| Americas | 99.93% |
| North America | 99.92% |
| Latin America | 0.01% |
| Greater Europe | 0.05% |
| United Kingdom | 0.01% |
| Europe Developed | 0.05% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.00% |
| Greater Asia | 0.01% |
| Japan | 0.00% |
| Australasia | 0.00% |
| Asia Developed | 0.01% |
| Asia Emerging | 0.00% |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00% |
FHLC Stock Sector Exposure
| Basic Materials | 0.00% |
| Communication Services | 0.00% |
| Consumer Cyclical | 0.00% |
| Consumer Defensive | 0.00% |
| Energy | 0.00% |
| Financial Services | 0.02% |
| Healthcare | 98.41% |
| Industrials | 0.07% |
| Real Estate | 0.00% |
| Technology | 1.50% |
| Utilities | 0.00% |
FHLC Stock Market Capitalization
| Giant | 47.73% |
| Large | 33.37% |
| Medium | 13.27% |
| Small | 5.13% |
| Micro | 0.50% |
FHLC Stock Style Exposure
| Large Cap Value | 24.63% |
| Large Cap Blend | 33.01% |
| Large Cap Growth | 23.75% |
| Mid Cap Value | 1.35% |
| Mid Cap Blend | 2.62% |
| Mid Cap Growth | 9.29% |
| Small Cap Value | 0.35% |
| Small Cap Blend | 1.57% |
| Small Cap Growth | 3.43% |
View More Holdings
As of Oct. 15, 2018
FHLC Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 8.79% | 139.84 | +2.40% |
| PFE | Pfizer Inc | 6.17% | 44.76 | +1.89% |
| UNH | UnitedHealth Group Inc | 6.12% | 268.67 | -1.43% |
| MRK | Merck & Co Inc | 4.57% | 71.80 | +0.81% |
| ABBV | AbbVie Inc | 3.31% | 92.14 | +0.25% |
| AMGN | Amgen Inc | 3.17% | 201.57 | -0.38% |
| MDT | Medtronic PLC | 3.11% | 96.92 | +0.38% |
| ABT | Abbott Laboratories | 2.95% | 70.01 | -1.32% |
| LLY | Eli Lilly and Co | 2.64% | 112.95 | +1.73% |
| GILD | Gilead Sciences Inc | 2.32% | 75.88 | -0.56% |
Advertisement
FHLC One Page Reports
- One Page Report Download
FHLC Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Fidelity Investments |
| Benchmark Index | |
|---|---|
MSCI USA IMI/Health Care GR USD |
100.0% |
FHLC Manager Info
| Name | Tenure |
|---|---|
| Alan Mason | 2.42 yrs |
| Diane Hsiung | 4.86 yrs |
| Greg Savage | 4.86 yrs |
| Jennifer Hsui | 4.86 yrs |
FHLC Net Fund Flows
| 1M | 32.28M |
| 3M | 161.95M |
| 6M | 184.39M |
| YTD | 381.97M |
| 1Y | 429.63M |
| 3Y | 475.40M |
| 5Y | 1.141B |
| 10Y | -- |
FHLC Risk Info
| Beta (5Y) | 0.9482 |
| Max Drawdown (All) | 20.41% |
| Historical Sharpe (10Y) | -- |
| Historical Sortino (All) | 1.798 |
| 30-Day Rolling Volatility | 16.20% |
| Daily Value at Risk (VaR) 1% (All) | 2.51% |
| Monthly Value at Risk (VaR) 1% (All) | 9.13% |
FHLC Fundamentals
| Dividend Yield TTM (10-17-18) | 1.27% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Weighted Average PE Ratio | 29.24 |
| Weighted Average Price to Sales Ratio | 1.976 |
| Weighted Average Price to Book Ratio | 4.316 |
| Weighted Median ROE | 13.84% |
| Weighted Median ROA | 4.10% |
| Forecasted Dividend Yield | 1.36% |
| Forecasted PE Ratio | 17.93 |
| Forecasted Price to Sales Ratio | 1.898 |
| Forecasted Price to Book Ratio | 4.018 |
| Number of Holdings | 348 |
FHLC Growth Estimates
| Forecasted 5 Yr Earnings Growth | 11.40% |
| Forecasted Book Value Growth | 6.37% |
| Forecasted Cash Flow Growth | 7.36% |
| Forecasted Earnings Growth | -1.70% |
| Forecasted Revenue Growth | 8.65% |
FHLC Attributes
| Key Dates | |
|---|---|
| Inception Date | 10/21/2013 |
| Termination Date | |
| Last Annual Report Date | 7/31/2018 |
| Last Prospectus Date | 11/29/2017 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Fixed Distribution Fund | No |
| High-Net Worth Individual Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
FHLC Excel Add-In Codes
- Name: =YCI("FHLC","name")
- Broad Asset Class: =YCI("FHLC", "broad_asset_class")
- Broad Category: =YCI("FHLC", "broad_category_group")
- Prospectus Objective: =YCI("FHLC", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
